XBIO vs. XOM
Compare and contrast key facts about Xenetic Biosciences, Inc. (XBIO) and Exxon Mobil Corporation (XOM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBIO or XOM.
Correlation
The correlation between XBIO and XOM is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
XBIO vs. XOM - Performance Comparison
Key characteristics
XBIO:
0.14
XOM:
0.78
XBIO:
0.76
XOM:
1.20
XBIO:
1.09
XOM:
1.14
XBIO:
0.11
XOM:
0.80
XBIO:
0.72
XOM:
2.63
XBIO:
14.79%
XOM:
5.71%
XBIO:
74.09%
XOM:
19.19%
XBIO:
-99.93%
XOM:
-62.40%
XBIO:
-99.89%
XOM:
-11.76%
Fundamentals
XBIO:
$6.57M
XOM:
$482.23B
XBIO:
-$2.66
XOM:
$8.03
XBIO:
0.00
XOM:
4.12
XBIO:
$1.85M
XOM:
$261.26B
XBIO:
$1.85M
XOM:
$67.90B
XBIO:
-$3.11M
XOM:
$56.62B
Returns By Period
In the year-to-date period, XBIO achieves a 6.77% return, which is significantly higher than XOM's 2.00% return. Over the past 10 years, XBIO has underperformed XOM with an annualized return of -43.75%, while XOM has yielded a comparatively higher 6.43% annualized return.
XBIO
6.77%
6.23%
0.47%
10.94%
-22.44%
-43.75%
XOM
2.00%
-1.01%
-3.90%
13.52%
15.30%
6.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
XBIO vs. XOM — Risk-Adjusted Performance Rank
XBIO
XOM
XBIO vs. XOM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Xenetic Biosciences, Inc. (XBIO) and Exxon Mobil Corporation (XOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XBIO vs. XOM - Dividend Comparison
XBIO has not paid dividends to shareholders, while XOM's dividend yield for the trailing twelve months is around 3.50%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBIO Xenetic Biosciences, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XOM Exxon Mobil Corporation | 3.50% | 3.57% | 3.68% | 3.22% | 5.70% | 8.44% | 4.92% | 4.74% | 3.66% | 3.30% | 3.69% | 2.92% |
Drawdowns
XBIO vs. XOM - Drawdown Comparison
The maximum XBIO drawdown since its inception was -99.93%, which is greater than XOM's maximum drawdown of -62.40%. Use the drawdown chart below to compare losses from any high point for XBIO and XOM. For additional features, visit the drawdowns tool.
Volatility
XBIO vs. XOM - Volatility Comparison
Xenetic Biosciences, Inc. (XBIO) has a higher volatility of 15.64% compared to Exxon Mobil Corporation (XOM) at 4.90%. This indicates that XBIO's price experiences larger fluctuations and is considered to be riskier than XOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
XBIO vs. XOM - Financials Comparison
This section allows you to compare key financial metrics between Xenetic Biosciences, Inc. and Exxon Mobil Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities